Sho Ueda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sho Ueda has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Yukio Sato
Department of Thoracic Surgery, Faculty of Medicine, University of Tsukuba , Tsukuba, Ibaraki 305‑8575
3 shared publications Masayuki Noguchi
Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 305-8576
2 shared publicationsMika Wakabayashi
Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045
2 shared publicationsSatoshi Yamashita
Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045
2 shared publications- Toshikazu Ushijima
Department of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan
2 shared publications Chitose Ogawa
Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan, 104-0045
1 shared publication
Latest Publications
- 1 July 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 64 (1)
Middle lobe pulmonary artery branch running ventral to the upper lobe pulmonary vein
European Journal of Cardio-Thoracic Surgery thanks Stefano Bongiolatti, Dominique Gossot and the other, anonymous reviewer(s) for their contribution to the peer review process of this article. ...
- 1 July 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 64 (1)
Middle lobe pulmonary artery branch running ventral to the upper lobe pulmonary vein
European Journal of Cardio-Thoracic Surgery thanks Stefano Bongiolatti, Dominique Gossot and the other, anonymous reviewer(s) for their contribution to the peer review process of this article. ...
- Open Access
- 27 July 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (31)
A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy
Somatic mutations are accumulated in normal human tissues with aging and exposure to carcinogens. If we can accurately count any passenger mutations in any single DNA molecule, since their quantity is much larger than driver mutations, we can sensitively detect mutation accumulation in polyclonal normal tissues. Duplex sequencing, which tags both DNA strands in one DNA molecule, enables accurate count of such mutations, but requires a very large number of sequencing reads for each single sample of human-genome size. Here, we reduced the genome size to 1/90 using the Bam HI restriction enzyme and established a cost-effective pipeline. The enzymatically cleaved and optimal sequencing (EcoSeq) method was able to count somatic mutations in a single DNA molecule with a sensitivity of as low as 3 × 10 −8 per base pair (bp), as assessed by measuring artificially prepared mutations. Taking advantages of EcoSeq, we analyzed normal peripheral blood cells of pediatric sarcoma patients who received chemotherapy ( n = 10) and those who did not ( n = 10). The former had a mutation frequency of 31.2 ± 13.4 × 10 −8 per base pair while the latter had 9.0 ± 4.5 × 10 −8 per base pair ( P < 0.001). The increase in mutation frequency was confirmed by analysis of the same patients before and after chemotherapy, and increased mutation frequencies persisted 46 to 64 mo after chemotherapy, indicating that the mutation accumulation constitutes a risk of secondary leukemia. EcoSeq has the potential to reveal accumulation of somatic mutations and exposure to environmental factors in any DNA samples and will contribute to cancer risk estimation.
- 27 July 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (31)
Open AccessA quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy
Somatic mutations are accumulated in normal human tissues with aging and exposure to carcinogens. If we can accurately count any passenger mutations in any single DNA molecule, since their quantity is much larger than driver mutations, we can sensitively detect mutation accumulation in polyclonal normal tissues. Duplex sequencing, which tags both DNA strands in one DNA molecule, enables accurate count of such mutations, but requires a very large number of sequencing reads for each single sample of human-genome size. Here, we reduced the genome size to 1/90 using the Bam HI restriction enzyme and established a cost-effective pipeline. The enzymatically cleaved and optimal sequencing (EcoSeq) method was able to count somatic mutations in a single DNA molecule with a sensitivity of as low as 3 × 10 −8 per base pair (bp), as assessed by measuring artificially prepared mutations. Taking advantages of EcoSeq, we analyzed normal peripheral blood cells of pediatric sarcoma patients who received chemotherapy ( n = 10) and those who did not ( n = 10). The former had a mutation frequency of 31.2 ± 13.4 × 10 −8 per base pair while the latter had 9.0 ± 4.5 × 10 −8 per base pair ( P < 0.001). The increase in mutation frequency was confirmed by analysis of the same patients before and after chemotherapy, and increased mutation frequencies persisted 46 to 64 mo after chemotherapy, indicating that the mutation accumulation constitutes a risk of secondary leukemia. EcoSeq has the potential to reveal accumulation of somatic mutations and exposure to environmental factors in any DNA samples and will contribute to cancer risk estimation.
- 6 April 2021
- Published by Taylor & Francis in Epigenomics
- Vol. 13 (8) , 565-576
Influence of Degree of DNA Degradation in Formalin-Fixed and Paraffin-Embedded Tissue Samples on Accuracy of Genome-Wide DNA Methylation Analysis
Aim: Depending upon the degree of DNA degradation of formalin-fixed and paraffin-embedded tissue samples, accuracy of measurement by Infinium MethylationEPIC BeadChip assay (Illumina, CA, USA) was ...
- 6 April 2021
- Published by Taylor & Francis in Epigenomics
- Vol. 13 (8) , 565-576
Influence of Degree of DNA Degradation in Formalin-Fixed and Paraffin-Embedded Tissue Samples on Accuracy of Genome-Wide DNA Methylation Analysis
Aim: Depending upon the degree of DNA degradation of formalin-fixed and paraffin-embedded tissue samples, accuracy of measurement by Infinium MethylationEPIC BeadChip assay (Illumina, CA, USA) was ...